Recombinant protein subunit vaccines, in which viral proteins such as the whole S glycoprotein or the recombinant RBD of the S glycoprotein, are injected intramuscularly, have the potential to elicit protection to the host against the viral infection. Here, ART4 is linked to viral infectious disease.